ScholarLens Back to search
2020•Unpublished venueRequires access

Outcomes of Osteonecrosis of the Femoral Head in Children and Adolescents with Sickle Cell Disease (SCD)

Adele Heib, Irene Chern, Regina Hanstein, Eric Daniel Fornari

Open publisher page 0 citations

Abstract

Purpose: Osteonecrosis of the femoral head (ONFH) is a common complication of SCD. We set out to describe clinical and radiographic outcomes of SCD patients ≤21 years with ONFH, who were treated with (1) core decompression (CD) or (2) CD plus bone marrow aspirate concentrate (BMAC) injection, (3) total hip arthroplasty (THA) or (4) observation alone. Methods: 114 hips in 73 SCD patients, 42% female, mean age 16.4 years (range, 5.7-21.9 years) with an ONFH diagnosis between 2006 and 2018 were …

About this research paper

What this paper is about

Purpose: Osteonecrosis of the femoral head (ONFH) is a common complication of SCD. We set out to describe clinical and radiographic outcomes of SCD patients ≤21 years with ONFH, who were treated with (1) core decompression (CD) or (2) CD plus bone marrow aspirate concentrate (BMAC) injection, (3) total hip arthroplasty (THA) or (4) observation alone. Methods: 114 hips in 73 SCD patients, 42% female, mean age 16.4 years (range, 5.7-21.9 years) with an ONFH diagnosis between 2006 and 2018 were …

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Purpose: Osteonecrosis of the femoral head (ONFH) is a common complication of SCD. We set out to describe clinical and radiographic outcomes of SCD patients ≤21 years with ONFH, who were treated with (1) core decompression (CD) or (2) CD plus bone marrow aspirate concentrate (BMAC) injection, (3) total hip arthroplasty (THA) or (4) observation alone. Methods: 114 hips in 73 SCD patients, 42% female, mean age 16.4 years (range, 5.7-21.9 years) with an ONFH diagnosis between 2006 and 2018 were …

Key concepts: Medicine, Femoral head, Surgery, Complication, Disease, Bone marrow, Radiography, Internal medicine

Back to paper searchBrowse research topicsOriginal source
Outcomes of Osteonecrosis of the Femoral Head in Children and Adolescents with Sickle Cell Disease (SCD) — Research Paper | ScholarLens